Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Clin Ther. 2020 Aug 12;42(9):1637–1648. doi: 10.1016/j.clinthera.2020.06.011

Table I.

Trials registered at clinicaltrials.gov.

Year Posted Study Country Product Control Target Patient Phase Clinical Trial
Probiotics
– Denmark Lactobacillus Placebo VRE Adult Recruiting NCT03560700
 2018 United States Align Probiotic Placebo MDR urinary pathogens Adult Recruiting NCT03644966
 2019 Taiwan Not specified Placebo VRE Adult Recruiting NCT03822819
 2019 Argentina Bioflora Placebo CRE Adult Not yet recruiting NCT03967301
 2019 Norway Labinic probiotic Placebo ESBL Newborns Not yet recruiting NCT04172012
 2020 United States Bacillus subtilis MRSA Adult Recruiting NCT04247854
Prebiotics
 2019 United States Inulin Placebo MDRO Adult Recruiting NCT03865706
 2019 United States KB109 SOC VRE, CRE, ESBL-E Adult Recruiting NCT03944369
 2019 United States* Inulin Placebo MDRO Pediatric Recruiting NCT04111471

CRE = carbapenem-resistant Enterobacteriaceae; ESBL = extended-spectrum beta-lactamase; ESBL-E = extended-spectrum beta-lactamase Escherichia coli; MDR = multidrug resistant; MDRO = multidrug-resistant organism; MRSA = methicillin-resistant Staphylococcus aureus; SOC = standard of care; VRE = vancomycin-resistant Enterococcus.

*

The authors of the present review are also the primary sponsors of this clinical trial.